Nutex Health, Inc. — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clinigence Holdings, Inc. (CLNH)
CIK: 0001479681
Period of Report: 2021-02-25

Reporting Person: Hosseinion Warren (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-25	Common Stock	J	894209	$2.04	Acquired	1151563	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-27	Director Stock Option (right to buy)	$	P	800000	Acquired		Common Stock (800000)	Direct
2019-03-19	Warrants to Puchase common stock	$6.67	P	21590	Acquired	2024-12-31	Common Stock (21590)	Direct

Footnotes

F1: Acquired as per merger exchange.

F2: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030
100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027
600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030